Inlyta (axitinib tablets - Pfizer) — Cigna
Differentiated thyroid carcinoma (papillary, follicular, oncocytic)
Initial criteria
- Patient is age ≥ 18 years
- Patient meets ONE of the following (i or ii):
- i. Patient has papillary or follicular thyroid carcinoma AND disease is refractory to radioactive iodine therapy
- OR ii. Patient has oncocytic (formerly Hürthle cell) carcinoma
Approval duration
1 year